Updated
Updated · KUTV 2News · Aug 19
Utah Mom, 39, Begins Rare Double-Lung Transplant Process for Stage 4 Cancer
Updated
Updated · KUTV 2News · Aug 19

Utah Mom, 39, Begins Rare Double-Lung Transplant Process for Stage 4 Cancer

2 articles · Updated · KUTV 2News · Aug 19

Summary

  • Kelsey Flake, a 39-year-old Utah mother of five, is scheduled to begin the transplant process Tuesday at Northwestern Medicine after Stage 4 lung cancer left her with 41% lung capacity and full-time oxygen use.
  • Her family said the cancer returned in both lungs in January after chemotherapy, surgery and immunotherapy, and continued to progress despite another aggressive round of treatment.
  • Northwestern's DREAM program offers double-lung transplants to highly selected patients whose advanced cancer is confined to the lungs and no longer responds to standard care; surgeons are expected to remove at least one lung first before listing her for donor lungs.
  • A July 8 JAMA study of 98 such patients found 100% estimated one-year survival among 17 transplant recipients versus 40.8% for medically managed patients, though researchers said longer-term outcomes still need study.
  • The treatment will keep Flake and her husband in Chicago for months while their five children initially remain in Utah, prompting fundraising for housing, travel, child care and transplant-related costs.

Insights

How did a healthy mother go from running marathons to needing a radical double-lung transplant for Stage 4 cancer?
With 2026 data revealing recurrences, is giving rare donor lungs to Stage 4 patients a medical miracle or an ethical dilemma?
Could a groundbreaking surgical technique that washes the chest cavity finally offer a cure for terminal lung cancer patients?